Who Paid My Doc
Vaxelis
Biological Vaccine
NDC 63361-243-10
General payments
$1,658,858
Research payments
$2,762,465
Through program year 2025, $1,658,858 in general payments and $2,762,465 in research payments were reported against Vaxelis (Vaccine).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
9 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $227,230 | 11,609 |
| 2024 | General | $430,920 | 22,330 |
| 2024 | Research | $947,537 | 6 |
| 2023 | General | $440,832 | 23,297 |
| 2023 | Research | $622,365 | 5 |
| 2022 | General | $360,825 | 21,358 |
| 2022 | Research | $596,282 | 1 |
| 2021 | General | $199,051 | 12,644 |
| 2021 | Research | $596,282 | 1 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 105 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 52 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
91,238 general · 13 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.